NCT06006013 2026-02-18
Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer
Emory University
Phase 2 Recruiting
Clinical Trials
5 trialsNCT06066333 2026-02-03
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT05036434 2026-01-23
ACCOMPLISH
National Cancer Center, Korea
Phase 2 Active not recruiting
NCT05634577 2025-06-19
A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT05563467 2025-04-02
PEMBR-01
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 2 Recruiting